🔎 Trials Near Me

Início › Mieloma Múltiplo › Carolina do Norte › Winston-Salem

Ensaios clínicos de Mieloma Múltiplo em Winston-Salem, NC

14 estudos para Mieloma Múltiplo estão buscando participantes em locais em Winston-Salem e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.

Texto oficial do estudo (Inglês)

Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

RecrutandoFase 3
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07391657

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

RecrutandoFase 2
  • Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem
Idades de 18 a 80 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07149857

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

RecrutandoFase 2
  • Wake Forest University, School of Medicine Dept. of Internal Medicine, Division of Hematology Oncology, Winston-Salem
Idades 60 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06052826

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

RecrutandoFase 3
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05552222

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

RecrutandoFase 1/2
  • Wake Forest Baptist Health /ID# 271294, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06953960

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

RecrutandoFase 3
  • Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07555938

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

RecrutandoFase 3
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT07764978

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

RecrutandoFase 1/2
  • Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 21 de jul. de 2026 · NCT06892522

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

RecrutandoFase 1
  • Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT05650632

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

RecrutandoFase 1
  • Wake Forest University Health Sciences, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT05137054

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

RecrutandoEstudo observacional
  • Wake Forest Baptist Health, Winston-Salem
Idades de 18 a 120 · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT01890486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RecrutandoFase 1/2
  • Atrium Wake Forest Baptist Medical Center, Winston-Salem
Idades 12 e acima · Todos os sexos · Atualizado em 24 de mar. de 2026 · NCT04988555

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

RecrutandoFase 1/2
  • Atrium Health Wake Forest Baptist, Winston-Salem
Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2025 · NCT06119685

Ensaios de Mieloma Múltiplo em outras cidades

Outros estudos em Winston-Salem

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.